FrontierBio

3 known investors

Frontier Bio develops lab-grown human tissues, starting with tissue-engineered blood vessels intended as vascular grafts to treat cardiovascular disease and trauma. It also commercializes human-based tissue models and tissue engineering services as alternatives to animal testing.